Bivalirudin
- Product NDC
- 70860-403
- 11-digit product format
- 708600403
- Labeler code
- 70860
- Product ID
- 70860-403_e670c25e-1572-4492-a6b5-4f42ba4b389a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bivalirudin
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- NDA211215
- Marketing category
- NDA
- Marketing start
- 2020-03-01
- Marketing end
- 0000-00-00
- Substance
- BIVALIRUDIN
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-403-51 | 70860040351 | 10 CARTON in 1 CARTON (70860-403-51) > 1 VIAL, SINGLE-DOSE in 1 CARTON (70860-403-50) > 50 mL in 1 VIAL, SINGLE-DOSE | 10 carton | 2020-03-01 | 0000-00-00 | No | No | Current |